The Long-Term Effects of Oral and Transdermal Postmenopausal Hormone Replacement Therapy on Nitric Oxide, Endothelin-1, Prostacyclin, and Thromboxane

This publication has 28 references indexed in Scilit:

• Different effects of oral and transdermal hormonal replacement on prostacyclin and thromboxane A2
  Published by Wolters Kluwer Health ,1999
• Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
  Fertility and Sterility, 1997
• Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women
  Atherosclerosis, 1995
• Estrogen Increases Endothelial Nitric Oxide by a Receptor Mediated System
  Biochemical and Biophysical Research Communications, 1995
• Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cells
  FEBS Letters, 1995
• Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women
  The American Journal of Cardiology, 1995
• Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause
  The Lancet, 1991
• Thromboxane dominance and prostacyclin deficiency in habitual abortion
  The Lancet, 1991
• Plasma endothelin levels in hypertension and chronic renal failure.
  Hypertension, 1990
• Secondary prevention of vascular disease by prolonged antiplatelet treatment
  BMJ, 1988